Stryker (FRA:SYK) FCF Margin % : 23.78% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Stryker FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Stryker's Free Cash Flow for the three months ended in Dec. 2023 was €1,268 Mil. Stryker's Revenue for the three months ended in Dec. 2023 was €5,332 Mil. Therefore, Stryker's FCF Margin % for the quarter that ended in Dec. 2023 was 23.78%.

As of today, Stryker's current FCF Yield % is 2.46%.

The historical rank and industry rank for Stryker's FCF Margin % or its related term are showing as below:

FRA:SYK' s FCF Margin % Range Over the Past 10 Years
Min: 7.15 Med: 13.78 Max: 19.44
Current: 15.27

During the past 13 years, the highest FCF Margin % of Stryker was 19.44%. The lowest was 7.15%. And the median was 13.78%.

FRA:SYK's FCF Margin % is ranked better than
88.47% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: -7.14 vs FRA:SYK: 15.27

Stryker FCF Margin % Historical Data

The historical data trend for Stryker's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker FCF Margin % Chart

Stryker Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

10.36

19.44

16.00

11.04

15.30

Stryker Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															15.67	6.59	10.73	18.37	23.78

Competitive Comparison of Stryker's FCF Margin %

For the Medical Devices subindustry, Stryker's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stryker's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stryker's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Stryker's FCF Margin % falls into.

Stryker FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Stryker's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	2875.712	/	18796.666
	=	15.30 %

Stryker's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	1268.211	/	5332.355
	=	23.78 %

Stryker FCF Margin % Related Terms

Thank you for viewing the detailed overview of Stryker's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Stryker (FRA:SYK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (FRA:SYK) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

SYK:USA SYK:Mexico 1SYK:Italy S1YK34:Brazil SYK:Austria

Address

2825 Airview Boulevard, Kalamazoo, MI, USA, 49002

Website

https://www.stryker.com

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.